Several of these fusion proteins including tTF-NGR remain thrombogenic in vitro, bind to their respective targets on endothelial cells, and upon intravenous infusion induce thrombosis, vascular blood pooling and disruption in blood vessels in several human solid tumors growing in athymic mice with subsequent tumor growth retardation and regression. This evidence concerns the gene RTN4R and neoplasm.